Insmed Incorporated Shares Are Trading Lower. The Company Announced Additional Results From the ASPEN Study of Brensocatib in Patients With Non-cystic Fibrosis Bronchiectasis.
Insmed Incorporated Shares Are Trading Lower. The Company Announced Additional Results From the ASPEN Study of Brensocatib in Patients With Non-cystic Fibrosis Bronchiectasis.
Insmed股票價格下跌。該公司宣佈了Brensocatib在非囊性纖維化支氣管擴張患者中的ASPEN研究的額外結果。
Insmed Incorporated Shares Are Trading Lower. The Company Announced Additional Results From the ASPEN Study of Brensocatib in Patients With Non-cystic Fibrosis Bronchiectasis.
Insmed股票價格下跌。該公司宣佈了Brensocatib在非囊性纖維化支氣管擴張患者中的ASPEN研究的額外結果。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。